Draft Commission Implementing Decision (EU) on the non-approval of terbutryn, 1,2-Benzisothiazol-3(2H)-one (BIT), and tetrahydro-1,3,4,6- tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD) as existing active substances for use in biocidal products of product-types 9, 9, and 12, respectively, in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (3 page(s), in English), (2 page(s), in English)